Logo

Sandoz Launches Pre-Filled Epinephrine Injection for Type 1 Allergic Reactions in the US

Share this

Sandoz Launches Pre-Filled Epinephrine Injection for Type 1 Allergic Reactions in the US

Shots:

  • Sandoz launches Symjepi (epinephrine- 0.3mg & 0.15mg) injection for the emergency treatment of Type 1 allergic reactions including anaphylaxis and will be available in adult and pediatric doses at pharmacy retail outlets in the US
  • The launch of Symjepi will address ongoing epinephrine auto-injector shortage- meeting the demands of patients with type 1 allergic reactions leading to death if left untreated
  • Symjepi is a single-dose- pre-filled syringe and device combination available as a cost-effective treatment option with a compact and user-friendly design for Type 1 including anaphylaxis to stinging and biting insects- allergen immuno-therapy- foods- drugs- diagnostic testing substances

Click here to read full press release/ article | Ref: Sandoz | Image: Snack Safely


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions